IDT Corporation Reports Record Second Quarter 2025 Results
Record levels of gross profit +16%; income from operations +77%; Adjusted EBITDA*…
Descartes Announces Fiscal 2025 Fourth Quarter and Annual Financial Results
Record Income from Operations WATERLOO, Ontario and ATLANTA, March 05, 2025 (GLOBE…
Kia Announces February 2025 Global Sales Results
February 2025 global sales of 253,850 units, up 4.5% Y/yOutside of Korea,…
Vireo Growth Inc. Announces Fourth Quarter and Full Year 2024 Results
– Company achieves record revenue, gross profit margin and operating income in…
Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025
March 04, 2025 07:00 ET | Source: Seres Therapeutics, Inc. CAMBRIDGE, Mass.,…
Euro NCAP to Launch New Round of 2025 Safety Results
WhatLatest Euro NCAP safety results published online and via social media.WhenWednesday 5…
GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December31, 2024 Financial Results
EL MONTE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc…
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025
SAN FRANCISCO and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
March 01, 2025 12:45 ET | Source: Celldex Therapeutics, Inc. - Greatly…
Longeveron Announces Full-Year 2024 Financial Results and Provides Business Update
Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left…